Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caligiuri

Showing results (641-650 of 1,066) with videos related to

Pageof 107
Sort By:
Blood|September 18, 2004
Donor-derived IL-15 is critical for acute allogeneic graft-versus-host diseaseBradley W Blaser, Sameek Roychowdhury, Daniel J Kim, et al.
Psychopharmacology Bulletin|January 1, 1994
Early course of new-onset tardive dyskinesia in older patientsJ P Lacro, P L Gilbert, J S Paulsen, et al.
Nature Immunology|January 19, 2023
YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8<sup>+</sup> T cellsShoubao Ma, Baofa Sun, Songqi Duan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 6, 2019
Adipocytes: A Novel Target for IL-15/IL-15Rα Cancer Gene TherapyRun Xiao, Anthony G Mansour, Wei Huang, et al.
International Journal of Molecular Sciences|May 13, 2026
Serum Neurofilament Light Chain and GFAP Levels Are Associated with Structural Brain Connectivity in Parkinson's DiseaseMaria Celeste Bonacci, Jolanda Buonocore, Camilla Calomino, et al.
Brain and Behavior|February 20, 2025
Volumetric Assessment and Graph Theoretical Analysis of Thalamic Nuclei in Essential TremorMaria Giovanna Bianco, Maria Eugenia Caligiuri, Camilla Calomino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2015
A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple MyelomaDon M Benson, Adam D Cohen, Sundar Jagannath, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 19, 2006
Direct and indirect effects of alloantibodies link neointimal and medial remodeling in graft arteriosclerosisOlivier Thaunat, Liliane Louedec, Jianping Dai, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2006
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responsesGiulia Fulci, Laura Breymann, Davide Gianni, et al.
Blood|August 4, 2005
Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemiaAndrew Mone, Shannon Puhalla, Susan Whitman, et al.
Pageof 107

Showing results (641-650 of 1,066) with videos related to

Sort By:
Pageof 107
Blood|September 18, 2004
Donor-derived IL-15 is critical for acute allogeneic graft-versus-host diseaseBradley W Blaser, Sameek Roychowdhury, Daniel J Kim, et al.
Psychopharmacology Bulletin|January 1, 1994
Early course of new-onset tardive dyskinesia in older patientsJ P Lacro, P L Gilbert, J S Paulsen, et al.
Nature Immunology|January 19, 2023
YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8<sup>+</sup> T cellsShoubao Ma, Baofa Sun, Songqi Duan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 6, 2019
Adipocytes: A Novel Target for IL-15/IL-15Rα Cancer Gene TherapyRun Xiao, Anthony G Mansour, Wei Huang, et al.
International Journal of Molecular Sciences|May 13, 2026
Serum Neurofilament Light Chain and GFAP Levels Are Associated with Structural Brain Connectivity in Parkinson's DiseaseMaria Celeste Bonacci, Jolanda Buonocore, Camilla Calomino, et al.
Brain and Behavior|February 20, 2025
Volumetric Assessment and Graph Theoretical Analysis of Thalamic Nuclei in Essential TremorMaria Giovanna Bianco, Maria Eugenia Caligiuri, Camilla Calomino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2015
A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple MyelomaDon M Benson, Adam D Cohen, Sundar Jagannath, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 19, 2006
Direct and indirect effects of alloantibodies link neointimal and medial remodeling in graft arteriosclerosisOlivier Thaunat, Liliane Louedec, Jianping Dai, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2006
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responsesGiulia Fulci, Laura Breymann, Davide Gianni, et al.
Blood|August 4, 2005
Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemiaAndrew Mone, Shannon Puhalla, Susan Whitman, et al.
Pageof 107